This video highlights our strategic integration of Decisive Consulting and FIECON with Herspiegel, creating a global partnership dedicated to advancing market access, health economics and outcomes research (HEOR), and go-to-market strategy for life sciences companies. Combining our deep scientific expertise, evidence-based strategies, and extensive commercial experience, we are better equipped to support clients throughout the product journey, from early asset development to successful launch and ongoing market optimization worldwide.
Transcript:
Mike Blackney:
Hello, I’m Mike Blackney, Head of Operations at FIECON, a Herspiegel company.
Esther Nzenza:
I’m Esther Nzenza, Founder of Decisive, now a Herspiegel company. While our names remain familiar, this marks an exciting new chapter.
Mike Blackney:
FIECON and Decisive have joined forces under the Herspiegel umbrella, creating a truly global powerhouse in health economics, market access, and commercialization strategy. Together we offer clients the full spectrum of expertise needed to navigate complexity and seize opportunity across the product lifecycle.
Esther Nzenza:
I think it’s fair to say that each of us brings a distinct strength—FIECON’s leadership in HEOR and HTA, Decisive’s bold, access-driven strategy, and Herspiegel’s proven commercial execution and market access capabilities in the U.S. Now united, we deliver scientific insight, evidence strategy, deep market intuition, and executional precision to ensure that brands are built to lead and to last.
Mike Blackney:
This integration allows us to scale our impact globally, guiding development and commercialization right through early asset strategy to launch readiness and market optimization.
Esther Nzenza:
We’re here to redefine what’s possible in market access and to help innovative therapies reach the patients who need them most. Our clients count on us during their most decisive moments, and we will continue to deliver with bold ideas and proven results.
Mike Blackney:
Together we are powering commercial success and expanding patient access.
Esther Nzenza:
You can visit our websites or reach out to us directly. Let’s look forward and shape the future of access together.
Transforming Market Access Strategy
The integration of Decisive and FIECON with Herspiegel significantly expands our expertise in market access and HEOR across the full product lifecycle. Together, we deliver comprehensive, data-driven strategies that empower life sciences clients to overcome complex challenges, accelerate market entry, and achieve sustained commercial success.
About Herspiegel
Herspiegel is a leading commercialization consulting firm that helps life science clients maximize their brand potential. With expertise spanning market access, medical affairs, marketing, and patient services, Herspiegel has supported over 150 pharmaceutical product launches across oncology, rare disease, biosimilars, and general medicine brands. Our team of MDs, PhDs, MBAs, and pharmacists deliver strategic insights and operational excellence to ensure commercial success.
About Decisive Consulting
Decisive Consulting, founded in 2020 to challenge assumptions around value, evidence, and access strategy. We are challenge agents and change enablers, we enjoy the “difficult” and the opportunity to bring the “what if” to a robust and well-argued debate. We believe there needs to be more creativity in access strategy to challenge the status quo and realize what’s possible. Our Rebel Thinking leads to breakthrough access results, even in challenging circumstances. Decisive has supported more than 45 companies since inception from early-stage portfolio design through to HTA strategy and execution across multiple countries.
About FIECON
FIECON is a global life sciences consultancy specializing in economic modeling, outcomes research, health technology assessments, value communications, and pricing and reimbursement strategies. With extensive experience supporting biotech, pharmaceutical, and medical technology companies, FIECON combine commercial strategy and technical rigor to ensure successful therapeutic launches worldwide. FIECON’s experienced team partners closely with clients, navigating complex market access environments to deliver impactful solutions that make a meaningful difference to patients globally.
